Evidence map›Paper›PMID 24776925›Full record

ArticlePloS one2014

Whole-exome sequencing for the identification of susceptibility genes of Kashin-Beck disease.

Zhenxing Yang, Yu Xu, Hongrong Luo, Xiaohong Ma, Qiang Wang, Yingcheng Wang, Wei Deng, Tao Jiang, Guangqing Sun, Tingting He and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Zhenxing YangPsychiatric Laboratory & Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China.
Yu XuBGI-Shenzhen, Shenzhen, Guangdong, P R China.
Hongrong LuoPsychiatric Laboratory & Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China.
Xiaohong MaPsychiatric Laboratory & Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China.
Qiang WangPsychiatric Laboratory & Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China.
Yingcheng WangPsychiatric Laboratory & Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China.
Wei DengPsychiatric Laboratory & Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China.
Tao JiangBGI-Shenzhen, Shenzhen, Guangdong, P R China.
Guangqing SunBGI-Shenzhen, Shenzhen, Guangdong, P R China.
Tingting HeBGI-Shenzhen, Shenzhen, Guangdong, P R China.
Jingchu HuBGI-Shenzhen, Shenzhen, Guangdong, P R China.
Yingrui LiBGI-Shenzhen, Shenzhen, Guangdong, P R China.
Jun WangBGI-Shenzhen, Shenzhen, Guangdong, P R China.
Tao LiPsychiatric Laboratory & Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China.
Xun HuState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China; Biobank Center, West China Hospital, Sichuan University, Chengdu, Sichuan, P R China.
BGI Group (China) · CNSichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify and investigate the susceptibility genes of Kashin-Beck disease (KBD) in Chinese population.

methodsWhole-exome capturing and sequencing technology was used for the detection of genetic variations in 19 individuals from six families with high incidence of KBD. A total of 44 polymorphisms from 41 genes were genotyped from a total of 144 cases and 144 controls by using MassARRAY under the standard protocol from Sequenom. Association was applied on the data by using PLINK1.07.

resultsIn the sequencing stage, each sample showed approximately 70-fold coverage, thus covering more than 99% of the target regions. Among the single nucleotide polymorphisms (SNPs) used in the transmission disequilibrium test, 108 had a p-value of <0.01, whereas 1056 had a p-value of <0.05. Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis indicates that these SNPs focus on three major pathways: regulation of actin cytoskeleton, focal adhesion, and metabolic pathways. In the validation stage, single locus effects revealed that two of these polymorphisms (rs7745040 and rs9275295) in the human leukocyte antigen (HLA)-DRB1 gene and one polymorphism (rs9473132) in CD2-associated protein (CD2AP) gene have a significant statistical association with KBD.

conclusionsHLA-DRB1 and CD2AP gene were identified to be among the susceptibility genes of KBD, thus supporting the role of the autoimmune response in KBD and the possibility of shared etiology between osteoarthritis, rheumatoid arthritis, and KBD.

Indexed as

Sequence AnalysisAdolescentAdultAgedAsian PeopleCase-Control StudiesExomeFemaleGenetic Predisposition to DiseaseGenotyping TechniquesHumansKashin-Beck DiseaseMaleMiddle AgedPolymorphism, GeneticYoung Adult

Identifiers

PMID24776925
PMCPMC4002427
OpenAlexW1980419160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.